Literature DB >> 27134509

Letter to the Editor: Should We Really Take Anti-Viral Therapy into Account in Chronic Hepatitis B Patients with Normal Liver Function?

Mohammad Hossein Khosravi1, Seyed Moayed Alavian2.   

Abstract

Entities:  

Keywords:  Aminotransferase; Antiviral Therapy; Chronic Hepatitis B; Liver Neoplasms; Treatment; Viruses

Mesh：

Substances：

Year:  2016        PMID： 27134509      PMCID： PMC4835614          DOI： 10.3346/jkms.2016.31.5.824

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN： 1011-8934            Impact factor:   2.153


× No keyword cloud information.
  6 in total

1.  Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.

Authors:  Ju-Yeon Cho; Yong-Han Paik; Won Sohn; Hyun Chin Cho; Geum-Youn Gwak; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Gut       Date:  2014-03-10       Impact factor: 23.059

2.  Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?

Authors:  Shahnaz Sali; Heidar Sharafi; Seyede Hoda Alavian; Seyed Moayed Alavian; Faranak Etesam; Shima Salimi; Muayad A Merza; Maryam Keshvari
Journal:  Diagn Microbiol Infect Dis       Date:  2015-02-20       Impact factor: 2.803

3.  Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.

Authors:  Ivan F N Hung; Ronnie T P Poon; Ching-Lung Lai; James Fung; Sheung-Tat Fan; Man-Fung Yuen
Journal:  Am J Gastroenterol       Date:  2008-07-04       Impact factor: 10.864

Review 4.  Obesity and liver cancer.

Authors:  Ester Vanni; Elisabetta Bugianesi
Journal:  Clin Liver Dis       Date:  2013-10-24       Impact factor: 6.126

5.  How can we make decision for patients with chronic hepatitis B according to hepatitis B virus (HBV) DNA level?

Authors:  Maryam Keshvari; Seyed Moayed Alavian; Heidar Sharafi
Journal:  Hepat Mon       Date:  2014-02-05       Impact factor: 0.660

6.  Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels.

Authors:  Junggyu Lee; Dong Hyun Sinn; Jung Hee Kim; Geum-Youn Gwak; Hye Seung Kim; Sin-Ho Jung; Yong-Han Paik; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Byung Chul Yoo; Seung Woon Paik
Journal:  J Korean Med Sci       Date:  2015-10-16       Impact factor: 2.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.